Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer
Glycolysis is elevated in many cancers. In this study, the authors show that lactoylglutathione, a by-product of methylglyoxal produced from increased glycolysis, is elevated in lung cancer in mouse models and humans, arguing reactive metabolite production can be a liability for cancers.
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2019
|
| Subjects: | |
| Online Access: | https://doaj.org/article/ffedc81cd29a41c396c00462dba0a351 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|